OSTX
OS Therapies Incorporated
NYSE MKT: OSTX · HEALTHCARE · BIOTECHNOLOGY
$1.70
+4.29% today
Updated 2026-04-30
Market cap
$77.20M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.98
Dividend yield
—
52W range
$1 – $3
Volume
0.6M
OS Therapies Incorporated (OSTX) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | $1.68B | $325891.00 | $509105.00 | $798082.00 | $5.54M |
| Cash & equivalents | $1.23B | $80788.00 | $171480.00 | $38982.00 | $5.53M |
| Current assets | $1.68B | $312815.00 | $496835.00 | $790032.00 | $5.53M |
| Total liabilities | $8.00B | $11.78M | $18.07M | $24.81M | $4.73M |
| Current liabilities | $2.10B | $3.50M | $6.15M | $24.71M | $4.63M |
| Long-term debt | — | $7.07M | $10.35M | — | — |
| Shareholder equity | $-6.33B | $-11.45M | $-17.56M | $-24.02M | $811487.00 |
| Retained earnings | $-6.34B | $-15.22M | $-21.60M | $-29.52M | $-40.40M |
| Accounts receivable | $430.49M | $231071.00 | $1145.00 | — | — |
| Inventory | — | — | — | — | — |
| Goodwill | — | — | — | — | — |